Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.77 USD | +0.08% | +16.75% | +11.96% |
05-15 | Transcript : Xencor, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM | |
05-10 | Wedbush Adjusts Xencor's Price Target to $36 From $34, Keeps Outperform Rating | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.46B | - | - | - | |||
115B | ||||||
107B | ||||||
22.31B | - | |||||
21.6B | - | |||||
18.23B | - |
- Stock Market
- Equities
- XNCR Stock
- Charts Xencor, Inc.
- Sector Chart